A study titled "The effects of hormone therapy on metabolic risk factors in postmenopausal Korean women" analyzed data from 2,005 postmenopausal Korean women to assess the impact of hormone therapy (HT) on metabolic syndrome (MetS) and body composition. Using modified National Cholesterol Education Program criteria, the study found that 22.1%
